Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, no par value per share
-
Shares outstanding
-
353,523,885
-
Total 13F shares
-
82,070,744
-
Share change
-
+1,882,256
-
Total reported value
-
$116,553,437
-
Put/Call ratio
-
196%
-
Price per share
-
$1.42
-
Number of holders
-
146
-
Value change
-
+$2,653,090
-
Number of buys
-
68
-
Number of sells
-
45
Institutional Holders of PRECIGEN, INC. - Common Stock, no par value per share (PGEN) as of Q2 2025
As of 30 Jun 2025,
PRECIGEN, INC. - Common Stock, no par value per share (PGEN) was held by
146 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
82,070,744 shares.
The largest 10 holders included
Patient Capital Management, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., BlackRock, Inc., VANGUARD GROUP INC, IRIDIAN ASSET MANAGEMENT LLC/CT, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, MORGAN STANLEY, Parkman Healthcare Partners LLC, and Schonfeld Strategic Advisors LLC.
This page lists
146
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.